Open the mobile version, with barcode scanning
Class III Ongoing

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Why: Failed Impurities/Degradation Specifications

Company
SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States
Reported
Jul 8, 2026
Recall started
Jun 1, 2026
Where sold
U.S. Nationwide
Amount
9,048 bottles
Full product description
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Lots / codes affected
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.